{
  "catalogId": "a10c98fd-e766-4fb6-aba1-50dc06e98d4b",
  "name": "BICALUTAMIDE TEVA ® 150 MG",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "140 83 31741 00",
  "treatmentDescriptions": "In patients with locally advanced prostate cancer (T3-T4  any N  M0  T1-T2  N+  M0)  Bicalutamide is indicated as immediate therapy either alone or as adjuvant to treatment by radical prostatectomy or radiotherapy. The management of patients with locally advanced  non-metastatic prostate cancer for whom surgical castration or other medical intervention is not considered appropriate or acceptable.",
  "termsOfIssue": "Prescription required",
  "form": "tablets",
  "route": "per os",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "BICALUTAMIDE",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "L02BB03",
      "name": "BICALUTAMIDE"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "BICALUTAMIDE INOVAMED 50 MG 28 F.C.TAB",
      "manufacturer": {
        "name": "אינובמד",
        "countryOfOrigin": "IL"
      },
      "strength": {
        "value": 0,
        "unit": ""
      },
      "quantity": {
        "value": 28.0,
        "unit": "units"
      },
      "packagingDescription": "BLISTER PVDC/ALUMINIUM",
      "shelfLife": "36",
      "storageConditions": "",
      "codes": {
        "moh": "7683",
        "yarpa": "39081",
        "pharmasoft": "2543"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 140.9013,
        "retailMargin": 25.0,
        "maxRetailPrice": 176.126625,
        "maxPriceWithVAT": 207.8294175
      }
    }
  ],
  "metadata": {
    "version": "1.4",
    "lastUpdated": "2025-07-31T22:09:12.974787"
  }
}